A scholarly research assessing adalimumab immunogenicity in juvenile idiopathic arthritis sufferers discovered that concomitant usage of methotrexate, a prescribed immunosuppressant commonly, was connected with lower immunogenicity toward adalimumab than in sufferers who had been receiving adalimumab being a monotherapy [72]

A scholarly research assessing adalimumab immunogenicity in juvenile idiopathic arthritis sufferers discovered that concomitant usage of methotrexate, a prescribed immunosuppressant…